Dimethylcurcumin (ASC-J9) is a small molecule that enhances androgen receptor degradation. It has been shown in research to inhibit the proliferation and invasion of castration-resistant prostate cancer cells in both in vitro and in vivo models, making it a compound of interest for oncology studies.